Cannabis Use More Common Than Smoking in Australia

Jul.15.2022
Cannabis Use More Common Than Smoking in Australia
A national survey in Australia found that cannabis use is more common than smoking, with 20% supporting regular use.

The latest National Drug Strategy Household Survey (NDSHS) has found that the use of cannabis is more common than smoking.


The Australian Institute of Health and Welfare compiled and released 2019 data on Friday, which surveyed approximately 20,000 individuals aged 14 and above on their attitudes towards drugs.


A recent survey revealed that 20% of respondents support regular use of marijuana, while the proportion of smokers was 15%. As the acceptance of marijuana continues to grow, more Australians are in favor of harsher punishments for tobacco use to reflect the national decline in smoking rates.


Approximately 85% of Australians support stricter enforcement to prohibit the provision of tobacco to minors, while around seven in ten people believe that the use of e-cigarettes should be restricted in public places. 72% of people support the restrictions on the use of e-cigarettes, with a lower approval rate of 61% in the Northern Territory.


At the same time, a record-breaking two-fifths of Australians now support the legalization of marijuana, representing an increase of 16% over the past decade.


In certain areas, including Sydney, the support for the legalization of marijuana is as high as 60%. In Melbourne, 57% of the population believes that the drug should be legalized for personal use, while 47% of Brisbane residents are in favor of its legalization.


These findings follow a growing global trend and support the legalization of marijuana for recreational use. Approximately 19 states in the United States have already legalized the drug, joining a series of countries including Canada, Spain, and Uruguay.


Jarryd Bartle, an associate lecturer and drug policy advisor at the Massachusetts Institute of Technology, has suggested that reforms in the US and around the world could be influenced by the growing trend towards support for legalizing marijuana in Australia. He stated, "This demonstrates that the legalization model can work here.


The legalization of marijuana has received a significant proportion of votes, indicating a trend of support particularly among young people in Australia. Evidence suggests that legalization will not increase the number of regular marijuana users nor will it encourage those under 18 to use it. These are positive indications for the legalization movement.


Currently, all states and territories have some form of decriminalization, but there are varying degrees in terms of what amount is considered for personal use and the extent of punishment.


In 1987, South Australia became the first state to decriminalize minor cannabis offenses, introducing the option of paying a fine instead of facing criminal charges. However, decriminalization is not the same as legalization.


Approximately 78% of people believe that possessing marijuana for personal use should not be a criminal offense (i.e. decriminalization of drugs), while one-fifth of people support regular marijuana use by adults – a 12% increase from 2010.


Nearly three-quarters of Australian respondents (78%) said they still wouldn't use cannabis even if it were legalized. The Australian Capital Territory, where cannabis has been decriminalized, had the highest interest in trying the drug with approximately 11% of people stating they would try it if legalized, while Tasmania had 7.5%.


The next NDSHS survey is set to begin later this month and will be completed by December 2022. This survey will provide the government with information for policy planning related to tobacco, alcohol, and other drugs.


I'm sorry, there is no text provided for me to translate. Please provide the text you would like translated.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
According to Reuters, Australia’s state of Victoria introduced legislation to give police and the state tobacco licensing regulator stronger powers to shut businesses selling illegal tobacco, with non-compliant operators facing fines of more than A$2.4 million and up to 20 years in prison.
Jun.05
Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India’s Directorate of Revenue Intelligence (DRI) seized approximately 300,000 illegal e-cigarettes and vaping devices worth more than ₹120 crore (approximately $14 million) during coordinated multi-state enforcement operations.
Regulations
May.22
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20